Vyomesh Joshi

Trabeya Pvt Ltd. operates as a data analytics and AI products and services company. Its products include springboard, kassandra, fides, astrea and sia. The firm offers artificial intelligence & machine learning, business intelligence & analytics, data engineering and automation solutions. The company is headquartered Colombo, Sri Lanka.

3D Printing Industry Ltd. operates as a global media company which provides three-dimensional (3D) printing and 3D scanning services. Its 3D printing application is used in aerospace, art and sculpture, education, business, consumers, crowd funding, design, entertainment, fashion, food, jewelry, medical and dental, and transportation sectors. The company is headquartered in London, the United Kingdom.

Aurvandil Acquisition Corp. is a newly-organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on February 10, 2021 and is headquartered in Irvine, CA.

Simbionix USA Corp. provides training and education solutions for medical professionals and the healthcare industry. Its products include ANGIO Mentor, ARTHRO Mentor and BRONCH Mentor, da Vinci Surgery, GI Mentor, LAP Mentor, PELVIC Mentor, PERC Mentor, URO Mentor and US Mentor. The firm operates through its offices located in Airport City and Cleveland. The company was founded in 1997 by Ran Bronstein and is headquartered in Littleton, CO.

Releviate Therapeutics LLC is a bio-pharmaceutical company that was founded in 2020. The private company is based in San Diego, CA. Releviate Therapeutics addresses the needs of patients suffering from neuropathic pain by deploying specific human monoclonal antibodies to inactivate certain matrix metalloproteinases (MMP-9 and MMP-14) and potentially improve patient outcomes. The company's first-in-class therapy directly targets pain with antibodies whose development is rooted in actual pain pathophysiology. The therapy is designed to reverse underlying pathophysiology leading to neuropathic pain, and initial indications address small fiber neuropathy and diabetic neuropathy. The company's approach is very similar to Abbvie's Humira, inactivating the master-switch that causes chronic pain. Sergey Sikora, Robert S. Sullivan, and Jackie Townsend Konstanturos founded the company, and Sergey Sikora has been the CEO since 2020.

Metamaterial, Inc. engages in the research and development of advanced materials and photonics. Its platform technology includes holography, lithography, and wireless sensing. It seeks to commercialize products in its platform technology. The company was founded on July 7, 1987 and is headquartered in Dartmouth, Canada.